Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Texas Pacific Land | TPL | Nov 22, 2024 | 1 730.00 | +14.15 |
Texas Roadhouse | TXRH | Nov 22, 2024 | 194.90 | +1.22 |
Textron | TXT | Nov 22, 2024 | 85.38 | +1.69 |
TFF Pharmaceuticals | TFFP | Nov 22, 2024 | 0.34 | -2.91 |
TFI International | TFII | Nov 22, 2024 | 148.73 | +0.47 |
TFMG Prime Cyber Security ETF | HACK | Nov 22, 2024 | 73.60 | +0.48 |
TFS Financial | TFSL | Nov 22, 2024 | 14.52 | +0.97 |
TG Therapeutics | TGTX | Nov 22, 2024 | 35.07 | +1.51 |
TH International | THCH | Nov 22, 2024 | 1.01 | 0.00 |
Thailand Invest Mkt Index MSCI Ishares | THD | Nov 22, 2024 | 63.83 | +1.04 |
Tharimmune | THAR | Nov 22, 2024 | 2.56 | -1.92 |
The Andersons | ANDE | Nov 22, 2024 | 48.21 | +0.67 |
The Arena Group | AREN | Nov 22, 2024 | 1.55 | +2.65 |
The Azek Company A | AZEK | Nov 22, 2024 | 50.98 | +2.35 |
The Baldwin Insurance Group A | BWIN | Nov 22, 2024 | 47.83 | +2.27 |
The Bancorp | TBBK | Nov 22, 2024 | 57.42 | +2.72 |
The Beauty Health A | SKIN | Nov 22, 2024 | 1.42 | +2.16 |
The Carlyle Group | CG | Nov 22, 2024 | 53.65 | +1.63 |
The Central And Eastern Europe Fund | CEE | Nov 22, 2024 | 12.22 | +0.65 |
The Charles Schwab D Pref | SCHW-D | Nov 22, 2024 | 25.16 | +0.20 |
The Charles Schwab J Pref | SCHW-J | Nov 22, 2024 | 20.68 | +0.10 |
The Cheesecake Factory | CAKE | Nov 22, 2024 | 46.56 | +0.47 |
The Chefs Warehouse | CHEF | Nov 22, 2024 | 44.74 | +2.01 |
The Communication Services Select Sector SPDR® Fund | XLC | Nov 22, 2024 | 96.88 | -0.22 |
The Cooper Companies | COO | Nov 22, 2024 | 100.80 | +0.89 |
The Duckhorn Portfolio | NAPA | Nov 22, 2024 | 10.99 | -0.54 |
The Ensign Group | ENSG | Nov 22, 2024 | 146.36 | -0.67 |
The European Equity Fund | EEA | Nov 22, 2024 | 8.39 | +0.36 |
The First Bancshares | FBMS | Nov 22, 2024 | 37.65 | +2.06 |
The Gabelli Healthcare & Wellness Trust | GRX | Nov 22, 2024 | 10.14 | +0.40 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.